J Psychiatr Res
June 6, 2026
Effect of a digital mindfulness intervention for mild-to-moderate late-life depression: A randomized controlled trial.
J Psychiatr Res
November 26, 2025
Michael van Ameringen, Vidhi Patel, Beth Patterson et al.
The etiology of OCD is complex and appears to involve multiple biological pathways. Imbalances in central serotonin, dopamine, and glutamate activities are widely thought to play a causative role. Despite strong evidence supporting first-line OCD pharmacotherapies, approximately 40-60 % of OCD patients remain unresponsive and are considered treatment resistant (TR). Although a range of agents...
J Psychiatr Res
March 17, 2025
Otto Simonsson, Sankalp Chaturvedi, Peter S. Hendricks et al.
2 citations
Previous research has investigated associations between psychedelic experiences and meditation practice, but knowledge gaps remain. Using a longitudinal research design with a sample of US residents between 18 and 50 years old (N = 13,012), we investigated associations between psychedelic-related and meditation-related variables. The follow-up survey was completed by 7484 respondents, of whom...
J Psychiatr Res
March 14, 2025
Aron Amaev, Jianmeng Song, Yasaman Kambari et al.
8 citations
Illness anxiety (IA) is characterized by worry or fear in response to living with a chronic illness or a preoccupation with having or acquiring a serious disease in conjunction with absent to mild somatic symptomatology. Death anxiety (DA) may underpin IA and is more common in individuals with life-threatening illness. Treatments for DA and IA, such as psychotherapy and antidepressant drugs,...
J Psychiatr Res
March 28, 2023
Speech graph analysis in obsessive-compulsive disorder: The relevance of dream reports.
J Psychiatr Res
September 1, 1996
Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients.